Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$277,094
+$712 QoQ
Shares Held
4,809
+5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,927
of 2,506 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lakeside Advisors, INC. holds $12,885,078 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,640 | $5,495,910 | |
| 2 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
8,840 | $1,116,845 | |
| 4 | NVO |
Novo Nordisk A S
|
15,950 | $764,643 | |
| 5 | LLY |
ELI LILLY & Co
|
522 | $626,102 | |
| 6 | AMGN |
Amgen Inc
|
1,346 | $487,413 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,809 | $277,094 | |
| 8 | PFE |
Pfizer Inc
|
10,293 | $247,855 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,094 | 4,809 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $276,382 | 4,557 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $245,696 | 4,555 | Shares | Sole | 2026-01-27 | |
| 2025-06-30 | $203,629 | 4,399 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $268,112 | 4,396 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $248,524 | 4,394 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $211,720 | 4,092 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||